OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
0379$0.1257

China Ever Grand Financial Leasing Group Co Ltd

Medical Equipment, Supplies & DistributionVerified

The company’s capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating minimal leverage, and a strong liquidity position with a current ratio of 2.25. Its market price of 0.117 HKD yields a price-to-book ratio of 0.71, suggesting the stock is trading at a discount to its book value. Profitability metrics are negative, with a return on equity of -30.91% and a return on assets of -25.7%, both significantly below the industry median for medical equipment and distribution firms. The company reported a net loss of 85.85 million HKD, with an operating loss of 54.99 million HKD, reflecting poor operational performance. The company’s revenue is distributed across four segments: Distribution, Manufacturing, Investment, and Financial Leasing. The Distribution Segment is the primary revenue driver, though the financial snapshot does not provide segment-specific revenue figures. The geographic exposure is not disclosed, but the company is headquartered in Hong Kong and operates in China, suggesting a regional focus. The company’s growth trajectory is negative, with a net loss in the latest reporting period. Analyst estimates show a revenue of 298.09 million HKD, but the company’s operating income is negative, indicating a lack of profitability. There is no indication of revenue growth in the near term. Risk factors include a low liquidity score, though no immediate liquidity flags were detected. The company has a low dilution risk, with no filing-based signals of potential share issuance. The valuation adjustments applied in the custom valuations do not indicate significant overvaluation or undervaluation. Recent events include the latest financial results showing a net loss and a negative operating income. No recent filings or transcripts were provided that would indicate significant operational or strategic changes.

30-day price · 0379+0.06 (+85.7%)
Low$0.06High$0.19Close$0.13As of22 May, 00:00 UTC
Profile
CompanyChina Ever Grand Financial Leasing Group Co Ltd
Ticker0379.HK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. China Ever Grand Financial Leasing Group Co Ltd operates in the healthcare sector, generating revenue through the distribution of medical and health products, manufacturing of food and nutritional products, investment activities, and financial leasing services.

Classification. The company is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

The company’s capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating minimal leverage, and a strong liquidity position with a current ratio of 2.25. Its market price of 0.117 HKD yields a price-to-book ratio of 0.71, suggesting the stock is trading at a discount to its book value. Profitability metrics are negative, with a return on equity of -30.91% and a return on assets of -25.7%, both significantly below the industry median for medical equipment and distribution firms. The company reported a net loss of 85.85 million HKD, with an operating loss of 54.99 million HKD, reflecting poor operational performance. The company’s revenue is distributed across four segments: Distribution, Manufacturing, Investment, and Financial Leasing. The Distribution Segment is the primary revenue driver, though the financial snapshot does not provide segment-specific revenue figures. The geographic exposure is not disclosed, but the company is headquartered in Hong Kong and operates in China, suggesting a regional focus. The company’s growth trajectory is negative, with a net loss in the latest reporting period. Analyst estimates show a revenue of 298.09 million HKD, but the company’s operating income is negative, indicating a lack of profitability. There is no indication of revenue growth in the near term. Risk factors include a low liquidity score, though no immediate liquidity flags were detected. The company has a low dilution risk, with no filing-based signals of potential share issuance. The valuation adjustments applied in the custom valuations do not indicate significant overvaluation or undervaluation. Recent events include the latest financial results showing a net loss and a negative operating income. No recent filings or transcripts were provided that would indicate significant operational or strategic changes.
Key takeaways
  • The company is trading at a discount to book value, with a price-to-book ratio of 0.71.
  • It is unprofitable, with a return on equity of -30.91% and a return on assets of -25.7%.
  • The company has a low debt-to-equity ratio of 0.02, indicating a conservative capital structure.
  • No immediate liquidity or dilution risks were identified in the latest filings.
  • The company’s revenue is derived from four segments, but segment-specific performance is not disclosed.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$95.2M
Gross profit$13.3M
Operating income-$55.0M
Net income-$85.9M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$334.0M
Total liabilities$56.3M
Total equity$277.7M
Cash & equivalents$49.2M
Long-term debt$6.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.12
Market cap$197.4M
Enterprise value$154.3M
P/E
Reported non-GAAP P/E
EV/Revenue1.6
EV/Op income
EV/OCF
P/B0.7
P/Tangible book0.7
Tangible book$277.7M
Net cash$43.1M
Current ratio2.2
Debt/Equity0.0
ROA-25.7%
ROE-30.9%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric0379Activity
Op margin-57.8%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-90.2%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin13.9%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue3.0% medp25 2.7% · p75 4.5%
Debt / equity2.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Observations
IR observations
Last actual EPS-1.66 HKD
Last actual revenue298,089,000 HKD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 20:52 UTC#58a9880c
Market quoteclose HKD 0.12 · shares 1.69B diluted
no public URL
2026-05-04 20:52 UTC#2d2d4e61
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 20:53 UTCJob: d5f4d24f